Phenotypic and mutational spectrum of ROR2-related Robinow syndrome.

HPO terms WNT pathway chromosome microarray analysis craniofacial morphology exonic deletion next-generation sequencing quantitative phenotyping cluster heatmap skeletal dysplasia

Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
07 2022
Historique:
revised: 23 03 2022
received: 24 06 2021
accepted: 24 03 2022
pubmed: 29 3 2022
medline: 10 6 2022
entrez: 28 3 2022
Statut: ppublish

Résumé

Robinow syndrome is characterized by a triad of craniofacial dysmorphisms, disproportionate-limb short stature, and genital hypoplasia. A significant degree of phenotypic variability seems to correlate with different genes/loci. Disturbances of the noncanonical WNT-pathway have been identified as the main cause of the syndrome. Biallelic variants in ROR2 cause an autosomal recessive form of the syndrome with distinctive skeletal findings. Twenty-two patients with a clinical diagnosis of autosomal recessive Robinow syndrome were screened for variants in ROR2 using multiple molecular approaches. We identified 25 putatively pathogenic ROR2 variants, 16 novel, including single nucleotide variants and exonic deletions. Detailed phenotypic analyses revealed that all subjects presented with a prominent forehead, hypertelorism, short nose, abnormality of the nasal tip, brachydactyly, mesomelic limb shortening, short stature, and genital hypoplasia in male patients. A total of 19 clinical features were present in more than 75% of the subjects, thus pointing to an overall uniformity of the phenotype. Disease-causing variants in ROR2, contribute to a clinically recognizable autosomal recessive trait phenotype with multiple skeletal defects. A comprehensive quantitative clinical evaluation of this cohort delineated the phenotypic spectrum of ROR2-related Robinow syndrome. The identification of exonic deletion variant alleles further supports the contention of a loss-of-function mechanism in the etiology of the syndrome.

Identifiants

pubmed: 35344616
doi: 10.1002/humu.24375
pmc: PMC9177636
mid: NIHMS1793937
doi:

Substances chimiques

ROR2 protein, human EC 2.7.10.1
Receptor Tyrosine Kinase-like Orphan Receptors EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

900-918

Subventions

Organisme : NHGRI NIH HHS
ID : UM1HG006542
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006542
Pays : United States
Organisme : NICHD NIH HHS
ID : R03 HD092569
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS105078
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM132589
Pays : United States

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Am J Med Genet A. 2020 Nov;182(11):2632-2640
pubmed: 32888393
Hum Genet. 2007 Nov;122(3-4):389-95
pubmed: 17665217
Am J Hum Genet. 2015 Apr 2;96(4):623-30
pubmed: 25817014
Am J Med Genet A. 2018 Mar;176(3):739-742
pubmed: 29383834
HGG Adv. 2021 Dec 03;3(1):100074
pubmed: 35047859
Am J Dis Child. 1969 Jun;117(6):645-51
pubmed: 5771504
Dev Dyn. 2010 Jan;239(1):327-37
pubmed: 19918918
Am J Med Genet A. 2021 Dec;185(12):3584-3592
pubmed: 32974972
Am J Med Genet A. 2021 Dec;185(12):3593-3600
pubmed: 33048444
Nat Rev Genet. 2016 Apr;17(4):224-38
pubmed: 26924765
Clin Genet. 2009 Apr;75(4):394-400
pubmed: 19236432
BMC Bioinformatics. 2014 Jan 29;15:30
pubmed: 24475911
Genet Med. 2019 Apr;21(4):798-812
pubmed: 30655598
Gene Expr Patterns. 2009 Oct;9(7):520-7
pubmed: 19595791
Genes Environ. 2016 Sep 01;38(1):17
pubmed: 27588157
Am J Hum Genet. 2018 Jan 4;102(1):27-43
pubmed: 29276006
Am J Med Genet A. 2021 Dec;185(12):3606-3612
pubmed: 33237614
Cell. 2011 Sep 30;147(1):32-43
pubmed: 21962505
Curr Top Dev Biol. 2017;123:105-142
pubmed: 28236965
Clin Genet. 2011 Jul;80(1):15-24
pubmed: 21496006
Am J Med Genet A. 2015 Dec;167A(12):3054-61
pubmed: 26284319
Am J Med Genet A. 2018 Apr;176(4):1030-1036
pubmed: 29575631
N Engl J Med. 2019 Jun 20;380(25):2478-2480
pubmed: 31216405
Am J Hum Genet. 2000 Oct;67(4):822-31
pubmed: 10986040
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Cell. 2019 Mar 7;176(6):1310-1324.e10
pubmed: 30827684
Nat Genet. 2000 Aug;25(4):423-6
pubmed: 10932187
Am J Med Genet A. 2007 Feb 15;143(4):320-5
pubmed: 17256787
J Med Genet. 1978 Apr;15(2):123-7
pubmed: 641945
Nat Genet. 2000 Aug;25(4):419-22
pubmed: 10932186
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Genome Med. 2017 Mar 21;9(1):26
pubmed: 28327206
Am J Hum Genet. 2015 Apr 2;96(4):612-22
pubmed: 25817016
Am J Med Genet A. 2021 Dec;185(12):3576-3583
pubmed: 32954672
Dev Dyn. 2004 Feb;229(2):400-10
pubmed: 14745966
Cell Mol Biol (Noisy-le-grand). 1999 Jul;45(5):653-9
pubmed: 10512196
Genome Res. 2018 Aug;28(8):1228-1242
pubmed: 29907612
Am J Hum Genet. 2016 Mar 3;98(3):553-561
pubmed: 26924530
Dev Dyn. 2009 May;238(5):1150-65
pubmed: 19334275
Am J Med Genet A. 2021 Nov;185(11):3294-3313
pubmed: 34405553
Am J Med Genet A. 2021 Dec;185(12):3601-3605
pubmed: 33277809
Hum Mol Genet. 2005 Sep 1;14(17):2559-69
pubmed: 16049033
Eur J Med Genet. 2012 Feb;55(2):103-8
pubmed: 22178368

Auteurs

Ariadne R Lima (AR)

Programa de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil.

Barbara M Ferreira (BM)

Programa de Pós-Graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brasil.

Chaofan Zhang (C)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Angad Jolly (A)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.

Haowei Du (H)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Janson J White (JJ)

Department of Pediatrics, University of Washington, Seattle, Washington, USA.

Moez Dawood (M)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Tulio C Lins (TC)

Programa de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.

Marcela A Chiabai (MA)

Programa de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.

Ellen van Beusekom (E)

Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Mara S Cordoba (MS)

Faculdade de Medicina, Universidade de Brasília, Brasília, DF, Brasil.
Hospital Universitário de Brasília, Brasília, Brasil.

Erica C C Caldas Rosa (ECC)

Programa de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil.

Hulya Kayserili (H)

Medical Genetics Department, School of Medicine (KUSoM), Koç University, Istanbul, Turkey.

Virginia Kimonis (V)

Division of Genetics and Genomic Medicine, Department of Pediatrics, University of California-Irvine, Irvine, California, USA.

Erica Wu (E)

Obstetrics and Gynecology, Stanford University, Stanford, California, USA.

Cecilia Mellado (C)

Unidad de Genética, División de Pediatría, Pontificia Universidad Católica de Chile, Santiago, Chile.

Vineet Aggarwal (V)

Department of Orthopedics, Indira Gandhi Medical College, Snowdon, India.

Antonio Richieri-Costa (A)

Hospital de Reabilitação de Anomalias Craniofaciais, Bauru, Brasil.

Décio Brunoni (D)

Universidade Presbiteriana Mackenzie-UPM, São Paulo, Brasil.

Talyta M Canó (TM)

Programa de Pós-Graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brasil.
Núcleo de Genética-SESDF, Brasília, DF, Brasil.

Alexander A L Jorge (AAL)

Laboratório de Endocrinologia Celular e Molecular LIM25, Disciplina de Endocrinologia da Faculdade de Medicina da Universidade de São Paulo, Unidade de Endocrinologia Genética, São Paulo, Brasil.

Chong A Kim (CA)

Unidade de Genética, Instituto da Criança-Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.

Rachel Honjo (R)

Unidade de Genética, Instituto da Criança-Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.

Débora R Bertola (DR)

Unidade de Genética, Instituto da Criança-Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil.
Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.

Raissa M Dandalo-Girardi (RM)

Programa de Mestrado Profissional em Aconselhamento Genético e Genômica Humana, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.

Yavuz Bayram (Y)

Department of Pathology and Laboratory Medicine, Division of Genomic Diagnostics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Alper Gezdirici (A)

Department of Medical Genetics, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.

Elif Yilmaz-Gulec (E)

School of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Evren Gumus (E)

Medical Genetics Department, Medicine Faculty, Mugla Sitki Kocman University, Mugla, Turkey.

Gülay C Yilmaz (GC)

Medical Genetics Department, Medicine Faculty, Mugla Sitki Kocman University, Mugla, Turkey.

Nobuhiko Okamoto (N)

Department of Medical Genetics, Osaka Women's and Children's Hospital, Osaka, Japan.

Hirofumi Ohashi (H)

Saitama Children's Medical Center, Division of Medical Genetics, Saitama, Japan.

Zeynep Coban-Akdemir (Z)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Department of Epidemiology, Human Genetics, and Environmental Sciences, Human Genetics Center, School of Public Health, UT Health, Houston, Texas, USA.

Tadahiro Mitani (T)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Shalini N Jhangiani (SN)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Donna M Muzny (DM)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Neysa A P Regattieri (NAP)

Faculdade de Medicina, Universidade de Brasília, Brasília, DF, Brasil.

Robert Pogue (R)

Programa de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.

Rinaldo W Pereira (RW)

Programa de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brasil.

Paulo A Otto (PA)

Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.

Richard A Gibbs (RA)

Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Bassam R Ali (BR)

Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.

Hans van Bokhoven (H)

Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

Han G Brunner (HG)

Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

V Reid Sutton (VR)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.

James R Lupski (JR)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Angela M Vianna-Morgante (AM)

Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brasil.

Claudia M B Carvalho (CMB)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Pacific Northwest Research Institute, Seattle, Washington, USA.

Juliana F Mazzeu (JF)

Programa de Pós-Graduação em Ciências da Saúde, Universidade de Brasília, Brasília, DF, Brasil.
Programa de Pós-Graduação em Ciências Médicas, Universidade de Brasília, Brasília, DF, Brasil.
Faculdade de Medicina, Universidade de Brasília, Brasília, DF, Brasil.
Robinow Syndrome Foundation, Anoka, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH